Valuation: Boston Scientific Corporation

Market Cap 61.74B 54.85B 51.2B 46.66B 88.01B 5,935B 88.83B 620B 240B 3,034B 232B 227B 9,737B P/E 2026 *
16.1x
P/E 2027 * 16.9x
Enterprise Value 70.47B 62.61B 58.43B 53.26B 100B 6,774B 101B 707B 274B 3,463B 265B 259B 11,114B EV / Sales 2026 *
3.32x
EV / Sales 2027 * 3.02x
Free-Float
82.47%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 61 31/10/2011
Director of Finance/CFO 52 29/06/2025
Chief Tech/Sci/R&D Officer - 31/08/2009
Director TitleAgeSince
Chairman 61 02/05/2016
Director/Board Member 74 28/02/2014
Director/Board Member 74 14/04/2016
Change 5-day change 1-year change 3-year change Capi.($)
+20.39%-.--% - - 61.74B
+0.35%-2.99%+24.73%+32.07% 242B
+1.09%-4.65%+1.77%+0.15% 150B
-2.32%-3.27%-11.53%+32.87% 138B
-1.46%-3.01%-55.73%-19.33% 61.74B
-0.05%-1.32%+11.09%+23.08% 49.08B
+0.66%+0.19%-19.29%-21.24% 47.43B
+0.66%-2.90%+20.97%+51.29% 47.3B
-3.05%-2.62%-9.13%+35.86% 44.25B
-0.08%-1.92%+32.09%+57.18% 41.78B
Average +1.88%-2.50%-0.56%+21.33% 91.4B
Weighted average by Cap. +1.56%-3.27%+3.37%+21.48%

Financials

2026 *2027 *
Net sales 21.2B 18.83B 17.58B 16.02B 30.22B 2,038B 30.5B 213B 82.43B 1,042B 79.58B 77.85B 3,343B 22.24B 19.76B 18.44B 16.81B 31.7B 2,138B 32B 223B 86.48B 1,093B 83.49B 81.68B 3,507B
Net income 3.79B 3.37B 3.14B 2.86B 5.4B 364B 5.45B 38.01B 14.73B 186B 14.22B 13.91B 597B 3.67B 3.26B 3.04B 2.77B 5.23B 353B 5.28B 36.83B 14.27B 180B 13.78B 13.48B 579B
Net Debt 8.73B 7.75B 7.24B 6.6B 12.44B 839B 12.56B 87.59B 33.94B 429B 32.77B 32.06B 1,377B 5.49B 4.88B 4.56B 4.15B 7.83B 528B 7.91B 55.14B 21.37B 270B 20.63B 20.18B 867B
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
42.60USD
Average target price
60.79USD
Spread / Average Target
+42.71%

Quarterly revenue - Rate of surprise